pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
bepranemab
Alzheimer's Disease
Microtubule-associated protein tau
UCB SA
0
catalysts
Marketed
beractant
Survanta (beractant)
Neonatal Respiratory Distress Syndrome
$ABBV
AbbVie Inc.
0
catalysts
Phase 2
berberine ursodeoxycholate
Primary Sclerosing Cholangitis
HighTide Therapeutics Inc
0
catalysts
← prev
page 159 of 231
next →
131
Pain
89
Neurology
1
Marketed
berdazimer sodium
Zelsuvmi (berdazimer sodium [INN])
Acne Vulgaris
$PTHS
Pelthos Therapeutics Inc.
0
catalysts
Marketed
beremagene geperpavec
Vyjuvek (beremagene geperpavec-svdt)
Dystrophic Epidermolysis Bullosa
$KRYS
Krystal Biotech, Inc.
0
catalysts
Phase 2
beroterkib
Solid Tumor
$MOS
MOSAIC CO
0
catalysts
Phase 2
bersiporocin
Idiopathic Pulmonary Fibrosis
Daewoong Pharmaceutical Co Ltd
0
catalysts
Marketed
besifloxacin hydrochloride
Besivance (besifloxacin hydrochloride)
Bacterial Conjunctivitis
$BLCO
Bausch & Lomb Corp
0
catalysts
Phase 1
besufetamig
besufetamig [INN]
Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy
Ono Pharmaceutical Co Ltd
0
catalysts
Phase 2
betahistine dihydrochloride
Vertigo
$CYTOF
Altamira Therapeutics Ltd.
0
catalysts
Marketed
betaine
Betaine
Homocystinuria
$ETON
Eton Pharmaceuticals, Inc.
0
catalysts
Marketed
betaine hydrochloride
Cystadane (betaine hydrochloride)
Homocystinuria
Recordati Rare Diseases Inc
0
catalysts
Phase 2
betamethasone
Keratoconjunctivitis Sicca (Dry Eye)
Glucocorticoid receptor
Surface Ophthalmics Inc
0
catalysts
Marketed
betamethasone valerate
Betamethasone Valerate (betamethasone valerate)
Atopic Dermatitis (Atopic Eczema)
Perrigo New York Inc
0
catalysts
Marketed
betaxolol hydrochloride
Betaxolol Hydrochloride (betaxolol hydrochloride)
Hypertension
KVK-Tech Inc
0
catalysts
Marketed
bethanechol chloride
Bethanechol Chloride (BETHANECHOL CHLORIDE)
Neurogenic Bladder Dysfunction
Upsher-Smith Laboratories LLC
0
catalysts
Marketed
betibeglogene autotemcel
Zynteglo (betibeglogene autotemcel)
Beta Thalassaemia
Genetix Biotherapeutics Inc
0
catalysts
pre_registration
bevacizumab biosimilar
Jobevne (bevacizumab-awwb)
Cervical Cancer
Vascular endothelial growth factor A, long form
Shanghai Henlius Biotech Inc
0
catalysts
Marketed
bexagliflozin
Brenzavvy (bexagliflozin)
Type 2 Diabetes
TheracosBio LLC
0
catalysts
Marketed
bexarotene
Targretin (bexarotene)
Cutaneous T-Cell Lymphoma
Bausch Health Americas Inc
0
catalysts
Phase 3
bexicaserin
Dravet Syndrome (Severe Myoclonic Epilepsy of Infancy)
Longboard Pharmaceuticals Inc
0
catalysts
Phase 2
bexmarilimab
Clevegen (bexmarilimab [INN])
Refractory Acute Myeloid Leukemia
Faron Pharmaceuticals Oy
0
catalysts
Phase 2
bexotegrast
Primary Sclerosing Cholangitis
$PLRX
PLIANT THERAPEUTICS, INC.
0
catalysts
Phase 3
bezisterim
Alzheimer's Disease
$BIVI
BIOVIE INC.
0
catalysts
Marketed
bezlotoxumab
Zinplava (bezlotoxumab)
Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Merck Sharp & Dohme Corp (Inactive)
0
catalysts
pre_registration
bezuclastinib
Gastrointestinal Stromal Tumor (GIST)
$COGT
Cogent Biosciences, Inc.
0
catalysts
Marketed
bicalutamide
Bicalutamide (bicalutamide)
Metastatic Prostate Cancer
Northstar Rx LLC
0
catalysts
Phase 3
bifikafusp alfa + onfekafusp alfa
Nidlegy (bifikafusp alfa [INN] + onfekafusp alfa [INN])
Metastatic Melanoma
Philogen SpA
0
catalysts
Phase 3
bimatoprost grenod
Ocular Hypertension
Kowa Co Ltd
0
catalysts
Marketed
bimekizumab
Bimzelx (bimekizumab)
Plaque Psoriasis (Psoriasis Vulgaris)
UCB SA
0
catalysts
